UCB9386 is the selective and brain penetrant inhibitor for Nuak1 with a pIC 50 of 10.1. UCB9386 inhibits Nuak2 and Kak2 with an inhibition rate of ca. 50% at 10 nM [1].
References:
[1]. Poullennec KG, et al., Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies. J Med Chem. 2024 Dec 12;67(23):20879-20910.
References:
[1]. Poullennec KG, et al., Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies. J Med Chem. 2024 Dec 12;67(23):20879-20910.
















